346 related articles for article (PubMed ID: 38397122)
41. L-Selectin/CD62L is a Key Driver of Non-Alcoholic Steatohepatitis in Mice and Men.
Drescher HK; Schippers A; Rosenhain S; Gremse F; Bongiovanni L; Bruin A; Eswaran S; Gallage SU; Pfister D; Szydlowska M; Heikenwalder M; Weiskirchen S; Wagner N; Trautwein C; Weiskirchen R; Kroy DC
Cells; 2020 Apr; 9(5):. PubMed ID: 32365632
[TBL] [Abstract][Full Text] [Related]
42. Deficiency in Tissue Non-Specific Alkaline Phosphatase Leads to Steatohepatitis in Mice Fed a High Fat Diet Similar to That Produced by a Methionine and Choline Deficient Diet.
Gámez-Belmonte R; Tena-Garitaonaindia M; Hernández-Chirlaque C; Córdova S; Ceacero-Heras D; de Medina FS; Martínez-Augustin O
Int J Mol Sci; 2020 Dec; 22(1):. PubMed ID: 33374541
[TBL] [Abstract][Full Text] [Related]
43. Human relaxin-2 attenuates hepatic steatosis and fibrosis in mice with non-alcoholic fatty liver disease.
Lee KC; Hsieh YC; Chan CC; Sun HJ; Huang YH; Hou MC; Lin HC
Lab Invest; 2019 Jul; 99(8):1203-1216. PubMed ID: 30918325
[TBL] [Abstract][Full Text] [Related]
44. Deleting Gata4 in hepatocytes promoted the progression of NAFLD via increasing steatosis and apoptosis, and desensitizing insulin signaling.
He L; Wang X; Ding Z; Liu L; Cheng H; Bily D; Wu C; Zhang K; Xie L
J Nutr Biochem; 2023 Jan; 111():109157. PubMed ID: 36150682
[TBL] [Abstract][Full Text] [Related]
45. Targeted Delivery of Stk25 Antisense Oligonucleotides to Hepatocytes Protects Mice Against Nonalcoholic Fatty Liver Disease.
Cansby E; Nuñez-Durán E; Magnusson E; Amrutkar M; Booten SL; Kulkarni NM; Svensson LT; Borén J; Marschall HU; Aghajan M; Mahlapuu M
Cell Mol Gastroenterol Hepatol; 2019; 7(3):597-618. PubMed ID: 30576769
[TBL] [Abstract][Full Text] [Related]
46. Loss of CEACAM1 in hepatocytes causes hepatic fibrosis.
Zaidi S; Asalla S; Muturi HT; Russo L; Abdolahipour R; Belew GD; Iglesias MB; Feraudo M; Leon L; Kuo E; Liu X; Kumarasamy S; Ghadieh HE; Gatto-Weis C; Zarrinpar A; Duarte S; Najjar SM
Eur J Clin Invest; 2024 Jul; 54(7):e14177. PubMed ID: 38381498
[TBL] [Abstract][Full Text] [Related]
47. Methionine restriction prevents the progression of hepatic steatosis in leptin-deficient obese mice.
Malloy VL; Perrone CE; Mattocks DA; Ables GP; Caliendo NS; Orentreich DS; Orentreich N
Metabolism; 2013 Nov; 62(11):1651-61. PubMed ID: 23928105
[TBL] [Abstract][Full Text] [Related]
48. Pleiotropic actions of IP6K1 mediate hepatic metabolic dysfunction to promote nonalcoholic fatty liver disease and steatohepatitis.
Mukherjee S; Chakraborty M; Ulmasov B; McCommis K; Zhang J; Carpenter D; Msengi EN; Haubner J; Guo C; Pike DP; Ghoshal S; Ford DA; Neuschwander-Tetri BA; Chakraborty A
Mol Metab; 2021 Dec; 54():101364. PubMed ID: 34757046
[TBL] [Abstract][Full Text] [Related]
49. Drug-Induced Fatty Liver Disease (DIFLD): A Comprehensive Analysis of Clinical, Biochemical, and Histopathological Data for Mechanisms Identification and Consistency with Current Adverse Outcome Pathways.
López-Pascual E; Rienda I; Perez-Rojas J; Rapisarda A; Garcia-Llorens G; Jover R; Castell JV
Int J Mol Sci; 2024 May; 25(10):. PubMed ID: 38791241
[TBL] [Abstract][Full Text] [Related]
50. StarD5 levels of expression correlate with onset and progression of steatosis and liver fibrosis.
Kakiyama G; Minoiwa K; Bai-Kamara N; Hashiguchi T; Pandak WM; Rodriguez-Agudo D
Am J Physiol Gastrointest Liver Physiol; 2024 Jun; 326(6):G747-G761. PubMed ID: 38591148
[TBL] [Abstract][Full Text] [Related]
51. Liver-specific loss of Perilipin 2 alleviates diet-induced hepatic steatosis, inflammation, and fibrosis.
Najt CP; Senthivinayagam S; Aljazi MB; Fader KA; Olenic SD; Brock JR; Lydic TA; Jones AD; Atshaves BP
Am J Physiol Gastrointest Liver Physiol; 2016 May; 310(9):G726-38. PubMed ID: 26968211
[TBL] [Abstract][Full Text] [Related]
52. Hepatocyte X-box binding protein 1 deficiency increases liver injury in mice fed a high-fat/sugar diet.
Liu X; Henkel AS; LeCuyer BE; Schipma MJ; Anderson KA; Green RM
Am J Physiol Gastrointest Liver Physiol; 2015 Dec; 309(12):G965-74. PubMed ID: 26472223
[TBL] [Abstract][Full Text] [Related]
53. MicroRNA-29a Disrupts DNMT3b to Ameliorate Diet-Induced Non-Alcoholic Steatohepatitis in Mice.
Yang YL; Kuo HC; Wang FS; Huang YH
Int J Mol Sci; 2019 Mar; 20(6):. PubMed ID: 30917489
[TBL] [Abstract][Full Text] [Related]
54. Partial leptin deficiency confers resistance to diet-induced obesity in mice.
Zhao S; Li N; Zhu Y; Straub L; Zhang Z; Wang MY; Zhu Q; Kusminski CM; Elmquist JK; Scherer PE
Mol Metab; 2020 Jul; 37():100995. PubMed ID: 32289482
[TBL] [Abstract][Full Text] [Related]
55. Silencing of STE20-type kinase MST3 in mice with antisense oligonucleotide treatment ameliorates diet-induced nonalcoholic fatty liver disease.
Caputo M; Kurhe Y; Kumari S; Cansby E; Amrutkar M; Scandalis E; Booten SL; Ståhlman M; Borén J; Marschall HU; Aghajan M; Mahlapuu M
FASEB J; 2021 May; 35(5):e21567. PubMed ID: 33891332
[TBL] [Abstract][Full Text] [Related]
56. Tumor necrosis factor alpha receptor 1 deficiency in hepatocytes does not protect from non-alcoholic steatohepatitis, but attenuates insulin resistance in mice.
Bluemel S; Wang Y; Lee S; Schnabl B
World J Gastroenterol; 2020 Sep; 26(33):4933-4944. PubMed ID: 32952340
[TBL] [Abstract][Full Text] [Related]
57. Molecular pathogenesis of metabolic dysfunction-associated steatotic liver disease, steatohepatitis, hepatic fibrosis and liver cirrhosis.
Saito T; Tsuchishima M; Tsutsumi M; George J
J Cell Mol Med; 2024 Jun; 28(12):e18491. PubMed ID: 38894579
[TBL] [Abstract][Full Text] [Related]
58. Skeletal muscle-specific Cre recombinase expression, controlled by the human α-skeletal actin promoter, improves glucose tolerance in mice fed a high-fat diet.
Al Batran R; Gopal K; Martin MD; Ho KL; Almutairi M; Aburasayn H; Eaton F; Campbell JE; Ussher JR
Diabetologia; 2018 Aug; 61(8):1849-1855. PubMed ID: 29858650
[TBL] [Abstract][Full Text] [Related]
59. Shifts in dietary carbohydrate-lipid exposure regulate expression of the non-alcoholic fatty liver disease-associated gene PNPLA3/adiponutrin in mouse liver and HepG2 human liver cells.
Hao L; Ito K; Huang KH; Sae-tan S; Lambert JD; Ross AC
Metabolism; 2014 Oct; 63(10):1352-62. PubMed ID: 25060692
[TBL] [Abstract][Full Text] [Related]
60. NAD
Li DJ; Sun SJ; Fu JT; Ouyang SX; Zhao QJ; Su L; Ji QX; Sun DY; Zhu JH; Zhang GY; Ma JW; Lan XT; Zhao Y; Tong J; Li GQ; Shen FM; Wang P
Theranostics; 2021; 11(9):4381-4402. PubMed ID: 33754067
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
